Almirall J, Gonzalez CA, Balanzo X, Bolibar I: Proportion of community-acquired pneumonia cases attributable to tobacco smoking.
Chest 1999, 116:375–379.
Article
CAS
PubMed
Google Scholar
Valdez R, Narayan KM, Geiss LS, Engelgau MM: Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults.
Am J Pub Health 1999, 89:1715–1721.
Article
CAS
Google Scholar
Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J, Sanchez M, Martinez JA: Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.
Am J Respir Crit Care Med 1999, 160:923–929.
Article
CAS
PubMed
Google Scholar
Chanock S: Evolving risk factors for infectious complications of cancer therapy.
Hematol Oncol Clin N Am 1993, 7:771–793.
CAS
Google Scholar
Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wun-derink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pen-nington J, Porter S: Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.
Lancet 1998, 351:929–933.
Article
CAS
PubMed
Google Scholar
McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR:Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
Ann Intern Med 1994,121:1–5.
Article
CAS
PubMed
Google Scholar
Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN:Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
N Engl J Med 1991,324:429–436.
Article
CAS
PubMed
Google Scholar
Beutler B, Milsark I, Cerami A:Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin.
Science 1985,229:869–871.
Article
CAS
PubMed
Google Scholar
Kindler V, Sappino A-P, Grau GE, Piguet P-F, Vassalli P:The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.
Cell 1989,56:731–740.
Article
CAS
PubMed
Google Scholar
Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahin-ian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW:Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to
L. monocytogenes
infection.
Cell 1993,73:457–467.
Article
CAS
PubMed
Google Scholar
Adams LB, Mason CM, Kolls JK, Scollard D, Krahenbuhl JL, Nelson S:Exacerbation of acute and chronic murine tuberculosis by administration of a TNF receptor expressing adenovirus.
J Infect Dis 1995,171:400–405.
Article
CAS
PubMed
Google Scholar
Kolls JK, Lei D, Greenberg S, Nelson S, Beutler B:Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense.
J Infect Dis 1995,171:570–575.
Article
CAS
PubMed
Google Scholar
Nelson S, Bagby GJ, Bainton B, Wilson LA, Thompson JJ, Summer WR:Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response.
J Infect Dis 1989,159:189–194.
Article
CAS
PubMed
Google Scholar
Boujoukos AJ, Martich GD, Supinski E, Suffredini AF:Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration.
J Appl Physiol 1993,74:3027–3033.
CAS
PubMed
Google Scholar
Dehoux MS, Boutten A, Ostinelli J, Seta N, Dombret MC, Crestani B, Deschenes M, Trouillet JL, Aubier M:Compartmentalized cytokine production within the human lung in unilateral pneumonia.
Am J Respir Crit Care Med 1994,150:710–716.
Article
CAS
PubMed
Google Scholar
Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP:Pathogenesis of septic shock in
Pseudomonas aeruginosa
pneumonia.
J Clin Invest 1999,104:743–750.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chiumello D, Pristine G, Slutsky AS:Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome.
Am J Respir Crit Care Med 1999,160:109–116.
Article
CAS
PubMed
Google Scholar
Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS:Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.
J Am Med Assoc 1999,282:54–61.
Article
CAS
Google Scholar
Tremblay LN, Slutsky AS:Ventilator-induced injury: from barotrauma to biotrauma.
Proc Assoc Am Physicians 1998,110:482–488.
CAS
PubMed
Google Scholar
Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W:Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.
Nat Med 1997,3:678–681.
Article
CAS
PubMed
Google Scholar
Volk HD, Reinke P, Docke WD:Clinical aspects: from systemic inflammation to `immunoparalysis'.
Chem Immunol 2000,74:162–177.
Article
CAS
PubMed
Google Scholar
Nelson S, Summer WR:Innate immunity, cytokines, pulmonary host defense.
Infect Dis Clin N Am 1998,12:555–567.
Article
CAS
Google Scholar
Hustinx WN, Van Kessel CP, Heezius E, Burgers S, Lammers JW, Hoepelman IM:Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia.
Clin Exp Immunol 1998,112:334–340.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nelson S, Belknap SM, Carlson RW, Dale D, DeBoisblanc B, Farkas S, Fotheringham N, Ho H, Marrie T, Movahhed H, Root R, Wilson J:A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.
J Infect Dis 1998,178:1075–1080.
Article
CAS
PubMed
Google Scholar
Daifuku R, Movahhed H, Fotheringham N, Bear MB, Nelson S:Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia.
Respir Med 1996,90:587–592.
Article
CAS
PubMed
Google Scholar
Williams LM, Snyder DC, Deblieux P, Ali J, Kuebel D, deBoisblanc BP, Summer WR:Safety and feasibility of combined aersolized and subcutaneous interferon-gamma as adjuvant treatement of
Mycobacterium avium
complex pulmonary infection in non-HIV infected hosts [abstract].
Am J Respir Crit Care Med 1994,149:A110-.
Article
Google Scholar
Condos R, Rom WN, Schluger NW:Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol.
Lancet 1997,349:1513–1515.
Article
CAS
PubMed
Google Scholar